Fingerprint
Dive into the research topics of 'A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically